SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-19-018042
Filing Date
2019-11-19
Accepted
2019-11-19 17:25:11
Documents
65
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 572294
2 ex31-1.htm EX-31.1 23261
3 ex31-2.htm EX-31.2 22342
4 ex32-1.htm EX-32.1 7593
5 ex32-2.htm EX-32.2 6920
  Complete submission text file 0001493152-19-018042.txt   4227453

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE matn-20190930.xml EX-101.INS 740916
7 XBRL SCHEMA FILE matn-20190930.xsd EX-101.SCH 51507
8 XBRL CALCULATION FILE matn-20190930_cal.xml EX-101.CAL 49420
9 XBRL DEFINITION FILE matn-20190930_def.xml EX-101.DEF 252211
10 XBRL LABEL FILE matn-20190930_lab.xml EX-101.LAB 343646
11 XBRL PRESENTATION FILE matn-20190930_pre.xml EX-101.PRE 317297
Mailing Address 701 GATEWAY BLVD. SUITE 210 SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD. SUITE 210 SOUTH SAN FRANCISCO CA 94080 650-635-7000
MATEON THERAPEUTICS INC (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21990 | Film No.: 191232392
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences